Literature DB >> 32432744

LncRNA NEAT1 regulated cell proliferation, invasion, migration and apoptosis by targeting has-miR-376b-3p/SULF1 axis in non-small cell lung cancer.

L-M Chen1, Y-D Niu, M Xiao, X-J Li, H Lin.   

Abstract

OBJECTIVE: Recently, lncRNA has been determined to play an important role in cancer formation and development. However, the regulatory mechanism of lncRNA in NSCLC has not been fully explored. PATIENTS AND METHODS: The expression of NEAT1, miR-376b-3p, and SULF1 was detected in each group via quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The proteins expression of SULF1, p-MAPK, MAPK, p-Akt, Akt, and GAPDH were measured via Western blot. MTT assay was applied to detect cell proliferation in each group. Transwell assay was used to assess cell invasion and migration of each group. Cell apoptosis was assessed with flow cytometry. The relationship among NEAT1, miR-376b-3p, and SULF1 was determined using Luciferase reporter assay.
RESULTS: In this study, the expression of NEAT1 and SULF1 was upregulated in NSCLC tissues and cells. Of note, the knockdown of NEAT1 and SULF1 could inhibit cell proliferation, migration, and invasion and promote cell apoptosis in NSCLC. Moreover, NEAT1 regulated SULF1 expression via binding to miR-376b-3p in NSCLC cells. Otherwise, the effects of NEAT1 on cell growth and apoptosis were reversed by improving the SULF1 expression in NSCLC cells. Meanwhile, si-NEAT1 transfection inhibited MAPK and Akt signaling pathway by modulating SULF1 in NSCLC cells.
CONCLUSIONS: In this study, we found that lncRNA NEAT1 regulated cell proliferation, invasion, migration, and apoptosis by targeting has-miR-376b-3p/SULF1 axis in NSCLC. Moreover, the regulatory network of NEAT1 participated in the phosphorylation levels of MAPK and Akt to affect cell progression of NSCLC, providing a new regulatory pathway in the pathogenesis of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32432744     DOI: 10.26355/eurrev_202005_21170

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  LncRNA NEAT1 promotes nucleus pulposus cell matrix degradation through regulating Nrf2/ARE axis.

Authors:  Cheng Li; Xinjian Ma; Chenfei Ni; Jingyan Xu; Yinfei Xie; Junwei Kan; Xiaoli Wei
Journal:  Eur J Med Res       Date:  2021-01-21       Impact factor: 2.175

2.  The Diagnostic and Prognostic Value of Serum lncRNA NEAT1 in Colorectal Cancer.

Authors:  Yong Wang; Dongsheng Zhang; Chuan Zhang; Yueming Sun
Journal:  Cancer Manag Res       Date:  2020-11-02       Impact factor: 3.989

Review 3.  Revisiting Lung Cancer Metastasis: Insight From the Functions of Long Non-coding RNAs.

Authors:  Peng Huang; Shaomi Zhu; Xin Liang; Qinxiu Zhang; Chi Liu; Linjiang Song
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

4.  MicroRNA-376b-3p targets RGS1 mRNA to inhibit proliferation, metastasis, and apoptosis in osteosarcoma.

Authors:  Lei Zhang; Meng Yao; Weikang Ma; Yongqing Jiang; Wenbo Wang
Journal:  Ann Transl Med       Date:  2021-11

Review 5.  NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential.

Authors:  Kun Li; Tongyue Yao; Yu Zhang; Wen Li; Ziqiang Wang
Journal:  Int J Biol Sci       Date:  2021-08-03       Impact factor: 6.580

Review 6.  The role of long non-coding RNAs in angiogenesis and anti-angiogenic therapy resistance in cancer.

Authors:  Junxia Liu; Qinqiu Zhang; Daolu Yang; Fei Xie; Zhaoxia Wang
Journal:  Mol Ther Nucleic Acids       Date:  2022-03-15       Impact factor: 10.183

Review 7.  Molecular Interactions of the Long Noncoding RNA NEAT1 in Cancer.

Authors:  Jingtao Gu; Bo Zhang; Rui An; Weikun Qian; Liang Han; Wanxing Duan; Zheng Wang; Qingyong Ma
Journal:  Cancers (Basel)       Date:  2022-08-19       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.